HAART for HIV in China--much achieved, more to be done.

摘要

First introduced in the mid-1990s, mainly in developed countries, highly active antiretroviral therapy (HAART) has resulted in unprecedented decreases in the morbidity and mortality caused by HIV/AIDS. To extend the benefits of HAART to resource-limited settings, which bear most of the HIV burden, a public health approach with standardised protocols for antiretroviral regimens, disease monitoring, and follow-up services has been advocated.